德曲妥珠单抗所致间质性肺病全程管理策略.
- Published in:
- China Oncology, 2024, v. 34, n. 12, p. 1067, doi. 10.19401/j.cnki.1007-3639.2024.12.001
- By:
- Publication type:
- Article
Works matching AU 胡夕春
Results: 7
1
2
原发灶不明肿瘤诊断与治疗研究进展.
- Published in:
- China Oncology, 2024, v. 34, n. 12, p. 1134, doi. 10.19401/j.cnki.1007-3639.2024.12.008
- By:
- Publication type:
- Article
3
中国抗癌协会多原发和不明原发肿瘤诊治 指南（2023年版）: 中国抗癌协会多原发和不明原发肿瘤专业委员会
- Published in:
- China Oncology, 2023, v. 33, n. 4, p. 403, doi. 10.19401/j.cnki.1007-3639.2023.04.001
- By:
- Publication type:
- Article
4
新型冠状病毒肺炎与抗肿瘤药物治疗.
- Published in:
- China Oncology, 2022, v. 32, n. 6, p. 499, doi. 10.19401/j.cnki.1007-3639.2022.06.004
- By:
- Publication type:
- Article
5
Trastuzumab deruxtecan的临床研究进展及 展望--HER2耐药患者的新希望.
- Published in:
- China Oncology, 2021, v. 31, n. 8, p. 754, doi. 10.19401/j.cnki.1007-3639.2021.08.009
- By:
- Publication type:
- Article
6
激素受体阳性转移性乳腺癌的内分泌治疗.
- Published in:
- Chinese Journal of Oncology, 2015, v. 37, n. 12, p. 881, doi. 10.3760/cma.j.issn.0253-3766.2015.12.001
- By:
- Publication type:
- Article
7
阿替利珠单抗治疗中国晚期实体瘤患者的开放标签Ⅰ期临床试验.
- Published in:
- Journal of Health Sciences of Peking University / Beijing Daxue Xuebao (Yixue Ban), 2022, v. 54, n. 5, p. 971, doi. 10.19723/j.issn.1671-167X.2022.05.026
- By:
- Publication type:
- Article